dose optimization trial

Pre-Open Stock Movers 05/20: (SRPT) (ISR) (PBY) Higher; (LPTN) (ETSY …
www.streetinsider.com

Genocea Biosciences (NASDAQ: GNCA) 21.5% HIGHER; announced positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. During the 28-day observation period immediately after completion of …

7
Like
Save
Genocea Biosciences (GNCA) Jumps: Stock Gains 8.8%
www.zacks.com

The upside was owing to the company's announcement of positive top-line data from a Phase 2 dose optimization trial evaluating GEN-003 for the treatment of genital herpes. This led to far more shares changing hands than in a normal session. The move …

9
Like
Save
ISR In All Its Radiance, GNCA's Herpes Drug Meets Trial Goal, AMAG On A High
www.nasdaq.com

phase II dose optimization trial evaluating GEN-003 for the treatment of genital herpes has demonstrated highly statistically significant 55% reduction in viral shedding rate with best dose of 60 µg per protein / 75 µg of Matrix-M2TM adjuvant. GNCA …

7
Like
Save
Genocea Completes Enrollment Early in Phase 2 Dose Optimization Trial of …
www.finances.com

… Inc. (NASDAQ:GNCA) , a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported that it has completed enrollment in its Phase 2 dose optimization clinical trial for GEN-003 for the treatment of genital herpes.

5
Like
Save
Genocea Reports Third Quarter 2014 Financial Results
www.marketwatch.com

I'm particularly pleased with enrollment in the Phase 2 dose optimization trial for our genital herpes program, GEN-003, reflecting both strong patient and physician motivation and our execution capabilities. We also initiated a Phase 2 trial for GEN …

6
Like
Save
Genocea Commences Phase 2 Dose Optimization Trial for GEN-003 HSV-2 …
www.marketwatch.com

The study is also designed to evaluate the impact on percentage of days with genital herpes lesions as reported by patients. Subjects receiving GEN-003 will be followed for 12 months after the last dose. Previously the Company announced results from …

5
Like
Save